An animal study looking at CD44 overexpression as stemness in breast cancer, found these conjugates were able to identify CD44+ cells where T2 signal was decreased by the magnetic nanoclusters in contrast with other tissue [51]. This evidence concerns the gene CD44 and breast carcinoma.